Characterizing biomarkers of Alzheimer's disease: A longitudinal multi-modal brain imaging study
Implementing Organization
Principal Investigator
Dr. Pravat K Mandal
Scientist VII
|
Neuroimaging and neurospectroscopy laboratory, National Brain Research Centre (NBRC), Manesar
CO-Principal Investigator
Dr Manjari Tripathi
AIIMS Delhi
About
The Neuroimaging and Neurospectroscopy lab is primarily interested in unraveling the Biomarkers for Alzheimer’s Disease (AD). The project aims at establishing the sequential relationship between the key structural, neurochemical, functional and behavioral alterations that occur in AD and identifying the earliest pathological event associated with AD onset by employing multi-modal imaging techniques (MRI, MRS, fMRI). AD related oxidative stress is attributed to the decrease in the Brain Glutathione (GSH) level. This study aims to assess aforementioned macroscopic changes.
We investigate the possible role of GSH and GABA in cognitive deficits manifested in AD.
For the analysis part of the data acquired from MRI and MRS, we have developed a novel software tool KALPANA (Indian and International Patent), which focuses on assessment and quantification of brain PH, glutathione (GSH) and GABA in various study groups including normal healthy control (HC), MCI and AD.
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.